Here are what the editors at HealthDay consider to be the most important developments in Urology for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Finasteride Not Tied to Increase in Prostate Cancer Mortality
TUESDAY, Jan. 29, 2019 (HealthDay News) — Finasteride is not associated with an increased risk for death due to prostate cancer, according to a research letter published in the Jan. 24 issue of the New England Journal of Medicine.
Machine Learning Methods Can Detect UTI in Dementia Patients
MONDAY, Jan. 28, 2019 (HealthDay News) — Algorithms that combine Internet of Things (IoT) technologies and in-home sensory devices with machine learning techniques can be used to monitor the health and well-being of people with dementia, according to a study published online Jan. 15 in PLOS ONE.
Report IDs Areas Lacking Good Practice in Health Tech Assessment
FRIDAY, Jan. 25, 2019 (HealthDay News) — In a report published in the January issue of Value in Health, an ISPOR–The Professional Society for Health Economics and Outcomes Research working group indicates the lack of good practices in three areas of health technology assessment (HTA).
FDA Down to 5 Weeks of Funding to Review New Drug Applications
THURSDAY, Jan. 17, 2019 (HealthDay News) — Due to the federal government shutdown, the U.S. Food and Drug Administration has only about five weeks of funding left to review new drug applications, according to Commissioner Scott Gottlieb, M.D.
Adoption of Advanced Health IT Capabilities Inconsistent
WEDNESDAY, Jan. 16, 2019 (HealthDay News) — Adoption of advanced health information technology (HIT) capabilities is inconsistent across health care systems, with electronic health record (EHR) standardization being the strongest predictor of advanced capabilities, according to a study published in the January issue of the American Journal of Managed Care.
Suicide Risk Up More Than Fourfold for Cancer Patients
WEDNESDAY, Jan. 16, 2019 (HealthDay News) — Cancer patients have an increased suicide risk, which is predominant among men and white patients, according to a study published online Jan. 14 in Nature Communications.
Personalized Tx May Extend Life in CKD With Small Renal Tumors
WEDNESDAY, Jan. 16, 2019 (HealthDay News) — Personalized treatment selection may extend life expectancy in patients with chronic kidney disease (CKD) and small renal tumors (≤4 cm), according to a study published online Jan. 15 in Radiology.
Study Explores Influence of Genetics, Environment in Disease
TUESDAY, Jan. 15, 2019 (HealthDay News) — The influence of heritability and environmental factors has been identified for a large number of phenotypes, according to a study published online Jan. 14 in Nature Genetics.
American College of Physicians Releases 7th Edition of Ethics Manual
TUESDAY, Jan. 15, 2019 (HealthDay News) — Ethical principles are discussed in an updated Ethics Manual, issued by the American College of Physicians (ACP) and published as a supplement to the Jan. 15 issue of the Annals of Internal Medicine.
Comorbidities Adversely Linked to Cancer Trial Participation
TUESDAY, Jan. 15, 2019 (HealthDay News) — For cancer patients, the presence of comorbidities is adversely linked to trial discussions, trial offers, and trial participation, according to a study published online Jan. 10 in JAMA Oncology.
Smoking Associated With Worse Bladder Cancer Outcomes
FRIDAY, Jan. 11, 2019 (HealthDay News) — Cigarette smoking is linked to a poor response to cisplatin-based neoadjuvant chemotherapy (NAC) among patients with muscle-invasive bladder cancer (MIBC) who undergo radical cystectomy (RC), according to a study published online Jan. 9 in BJU International.
Prices Still Explain High U.S. Health Care Spending
FRIDAY, Jan. 11, 2019 (HealthDay News) — The difference in health spending between the United States and other countries is still explained by health care prices, according to a study published in the January issue of Health Affairs.
Doctors Question State Lawsuits Over Pelvic Mesh Products
THURSDAY, Jan. 10, 2019 (HealthDay News) — State lawsuits over pelvic mesh products could scare women away from the products or even get them removed from the market, a group of doctors say.
Private Equity Acquisition of Physician Practices Discussed
THURSDAY, Jan. 10, 2019 (HealthDay News) — The phenomenon of private equity acquisition of physician practices is discussed in an Ideas and Opinions piece published online Jan. 8 in the Annals of Internal Medicine.
Many Female Health Care Workers Live in Poverty
WEDNESDAY, Jan. 9, 2019 (HealthDay News) — Many U.S. female health care workers, particularly women of color, live in poverty and lack health insurance, according to a study published online Dec. 20 in the American Journal of Public Health.
Increase in Brand-Name Drug Cost Mainly Due to Existing Drugs
WEDNESDAY, Jan. 9, 2019 (HealthDay News) — The costs of oral and injectable brand-name drugs increased from 2008 to 2016, with most of the increase due to existing drugs, while new drugs accounted for cost increases in specialty and generic drugs, according to a study published in the January issue of Health Affairs.
Medical Marketing Has Increased in Past 20 Years
TUESDAY, Jan. 8, 2019 (HealthDay News) — From 1997 through 2016, there was an increase in medical marketing, especially direct-to-consumer (DTC) advertising, according to research published in the Jan. 1/8 issue of the Journal of the American Medical Association.
Toxicity From All-Grade AEs in Prostate CA Better Reflects QOL
TUESDAY, Jan. 8, 2019 (HealthDay News) — In prostate cancer, patient- and clinician-based cumulative toxicity scores comprising all-grade adverse events (AEs) better reflect the impact on patient quality of life (QoL) than scores comprising high-grade AEs only, according to a study published in the December issue of the Journal of the National Comprehensive Cancer Network.
ACA Coverage Gains Could Erode Without Individual Mandate
TUESDAY, Jan. 8, 2019 (HealthDay News) — Eliminating the Affordable Care Act’s individual mandate penalty is unlikely to destabilize the individual market in California but could roll back coverage gains, according to a study published in the January issue of Health Affairs.
Cancer Death Rate in U.S. Decreased Continuously From 1991 to 2016
TUESDAY, Jan. 8, 2019 (HealthDay News) — The overall cancer death rate decreased continuously by 27 percent from 1991 to 2016, according to a report published online Jan. 8 in CA: A Cancer Journal for Clinicians.
Copyright © 2019 ScoutNews, LLC. All rights reserved.